Home

Jeffrey Paley

CIK 1595327 · last filed 2023-12-08

Jeffrey Paley is a corporate insider who has filed 14 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider sold $8.8K of DERM on Dec 8, 2023. Across all open-market trades the lifetime net is −$51.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $819.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$819.6K

Companies

4

Total Filings

14

Lifetime Open-Market Net

-$51.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DERM Director 114,472 $7.16 $819.6K $115.9K 7 2023-12-08
AVENUE THERAPEUTICS, INC. (ATXI) Delisted Director 71 $0.35 $25 $78.6K 2 2018-12-12
IMMUNE PHARMACEUTICALS INC (IMNP) Delisted Director — — — $0 3 2017-01-27
Travere Therapeutics, Inc. (RTRX) Delisted Director 51,665 — — -$245.6K 1 2014-08-18

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-08 DERM Sell (S) −2,500 -$8.8K EDGAR
2023-11-29 DERM Sell (S) −1,745 -$9.1K EDGAR
2023-10-10 DERM Buy (P) +15,000 $44.7K EDGAR
2023-09-25 DERM Buy (P) +30,000 $89.1K EDGAR
2023-07-25 DERM Grant (A) +27,472 $0 EDGAR
2022-07-25 DERM Grant (A) +14,245 $0 EDGAR
2022-04-04 DERM Grant (A) +30,000 $0 EDGAR
2018-12-12 AVENUE THERAPEUTICS, INC. (ATXI) Delisted Buy (P) +15,000 $78.6K EDGAR
2018-08-08 AVENUE THERAPEUTICS, INC. (ATXI) Delisted Gift (G) +14,663 $0 EDGAR
2017-01-27 IMMUNE PHARMACEUTICALS INC (IMNP) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.